Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms
Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms
Recruiting · NCT07693452 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, mucinous adenocarcinoma, neoplasm, pseudomyxoma peritonei | Recruiting | Phase 2 | 2026-07-13 | NCT07693452 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of California, Irvine | 157 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chao Family Comprehensive Cancer Center, University of California, Irvine | Orange | United States | 24 |